SCHEMBL1671168

SCHEMBL1671168

C#Cc1cc([C@@H]2O[C@H](CO)[C@@H](O)[C@@]2(C)O)n2ncnc([AsH2])c12

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 2/20 0.33
▸ ADK P55263 1/20 0.31
▸ DOT1L Q8TEK3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644948 0.89 ADORA2A (0.41) ADORA2AADKDOT1L
SCHEMBL646988 0.79 ADORA2A (0.41) ADORA2A
SCHEMBL13519772 0.79 ADORA2A (0.41) ADORA2A
SCHEMBL648257 0.77 ADORA2A (0.40) ADORA2A
SCHEMBL13519782 0.77 ADORA2A (0.44) ADORA2A
SCHEMBL13531953 0.76 ADORA2A (0.43) ADORA2AADK
SCHEMBL645160 0.75 ADORA2A (0.43) ADORA2A
SCHEMBL646044 0.75 ADORA2A (0.43) ADORA2A
SCHEMBL13531963 0.75 ADORA2A (0.43) ADORA2A
SCHEMBL7598953 0.75 ADORA2A (0.43) ADORA2AADKDOT1L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2313102-A2 BYCYCLIC NUCLEOSIDES AND NUCLEOTIDES AS THERAPEUTIC AGENTS Biota Scientific Management (AU) 2011-04-27 — — EP disclosed
WO-2010002877-A2 BYCYCLIC NUCLEOSIDES AND NUCLEOTIDES AS THERAPEUTIC AGENTS BIOTA SCIENTIFIC MANAGEMENT (AU) 2010-01-07 — — WO disclosed
Send feedback